Victrex PLC is a leading manufacturer of high-performance polymers and polymer-based solutions. Established in 1993 as a spin-off from Imperial Chemical Industries (ICI), Victrex PLC has become a global leader in the design, development, and production of high-performance polymers used in a wide range of industries.
The company's flagship product is PEEK (polyether ether ketone), a high-performance polymer which is known for its exceptional mechanical, thermal, and chemical properties. PEEK is used in a wide range of applications, including aerospace, automotive, electronics, energy, medical, and industrial.
Victrex PLC is headquartered in the UK, and has operations and sales offices in Europe, the Americas, and Asia. With a workforce of over 900 employees, the company is committed to delivering outstanding results for its customers and stakeholders.
1993
Served areaWorldwide
Headcount1,093
HeadquartersVictrex Technology Centre, Hillhouse International, FY5 4QD Thornton Cleveleys – United Kingdom
Line item in (gbp) | 01.10.2020 | 01.10.2021 | 01.10.2022 |
---|---|---|---|
Assets | N/A | 615,300,000.00 | 641,600,000.00 |
Noncurrent Assets | N/A | 377,700,000.00 | 410,000,000.00 |
Property Plant And Equipment | N/A | 305,700,000.00 | 347,200,000.00 |
Investments In Subsidiaries | N/A | 0.00 | 0.00 |
Investments In Associates | N/A | 11,400,000.00 | 10,400,000.00 |
Deferred Tax Assets | N/A | 8,900,000.00 | 7,200,000.00 |
Noncurrent Financial Assets At Fair Value Through Profit Or Loss | N/A | 12,700,000.00 | 10,100,000.00 |
Noncurrent Recognised Assets Defined Benefit Plan | N/A | 14,200,000.00 | 14,900,000.00 |
Current Assets | N/A | 237,600,000.00 | 231,600,000.00 |
Inventories | N/A | 70,300,000.00 | 86,800,000.00 |
Trade And Other Current Receivables | N/A | 49,100,000.00 | 68,100,000.00 |
Other Current Financial Assets | N/A | 37,500,000.00 | 10,100,000.00 |
Cash and cash equivalents | N/A | 74,900,000.00 | 58,700,000.00 |
Current Derivative Financial Assets | N/A | 2,900,000.00 | 0.00 |
Equity | 481,000,000.00 | 511,700,000.00 | 490,600,000.00 |
Issued Capital | N/A | 900,000.00 | 900,000.00 |
Retained Earnings | N/A | 445,400,000.00 | 427,200,000.00 |
Share Premium | N/A | 61,100,000.00 | 61,500,000.00 |
Equity Attributable To Owners Of Parent | N/A | 509,200,000.00 | 488,800,000.00 |
Noncontrolling Interests | N/A | 2,500,000.00 | 1,800,000.00 |
Liabilities | N/A | 103,600,000.00 | 151,000,000.00 |
Noncurrent Liabilities | N/A | 47,600,000.00 | 66,400,000.00 |
Noncurrent Provisions For Employee Benefits | N/A | 1,900,000.00 | 2,700,000.00 |
Deferred Tax Liabilities | N/A | 31,600,000.00 | 34,300,000.00 |
Longterm Borrowings | N/A | 5,900,000.00 | 21,600,000.00 |
Current Liabilities | N/A | 56,000,000.00 | 84,600,000.00 |
Trade And Other Current Payables | N/A | 49,400,000.00 | 59,700,000.00 |
Current Derivative Financial Liabilities | N/A | 1,900,000.00 | 19,900,000.00 |
Line item in (gbp) | 01.10.2020/ 01.10.2021 |
01.10.2021/ 01.10.2022 |
---|---|---|
Revenue | 306,300,000.00 | 341,000,000.00 |
Profit Loss From Operating Activities | 93,400,000.00 | 88,500,000.00 |
Finance Income | 200,000.00 | 500,000.00 |
Finance Costs | 200,000.00 | 300,000.00 |
Share Of Profit Loss Of Associates And Joint Ventures Accounted For Using Equity Method | -900,000.00 | -1,000,000.00 |
Profit Loss Before Tax | 92,500,000.00 | 87,700,000.00 |
Income Tax Expense Continuing Operations | 19,700,000.00 | 12,200,000.00 |
Profit (loss) | 72,800,000.00 | 75,500,000.00 |
Profit Loss Attributable To Owners Of Parent | 73,200,000.00 | 76,200,000.00 |
Profit Loss Attributable To Noncontrolling Interests | -400,000.00 | -700,000.00 |
Line item in (gbp) | 01.10.2021 | 01.10.2022 |
---|---|---|
Profit (loss) | 72,800,000.00 | 75,500,000.00 |
Adjustments For Decrease Increase In Inventories | 26,000,000.00 | -13,400,000.00 |
Adjustments For Sharebased Payments | 1,400,000.00 | 1,800,000.00 |
Adjustments For Losses Gains On Disposal Of Noncurrent Assets | 800,000.00 | 2,400,000.00 |
Cash Flows From Used In Operations | 135,500,000.00 | 90,700,000.00 |
Interest Paid Classified As Operating Activities | 0.00 | 400,000.00 |
Interest Received Classified As Operating Activities | 200,000.00 | 300,000.00 |
Cash Flows From Used In Operating Activities | 127,100,000.00 | 80,000,000.00 |
Purchase Of Property Plant And Equipment Classified As Investing Activities | 41,900,000.00 | 45,500,000.00 |
Cash Advances And Loans Made To Other Parties Classified As Investing Activities | 3,800,000.00 | 2,300,000.00 |
Dividends Received Classified As Investing Activities | 0.00 | 0.00 |
Cash Flows From Used In Investing Activities | -83,200,000.00 | -16,200,000.00 |
Proceeds From Issuing Shares | 6,100,000.00 | 400,000.00 |
Proceeds From Borrowings Classified As Financing Activities | 0.00 | 14,500,000.00 |
Payments Of Lease Liabilities Classified As Financing Activities | 1,800,000.00 | 2,100,000.00 |
Dividends Paid Classified As Financing Activities | 51,600,000.00 | 95,200,000.00 |
Cash Flows From Used In Financing Activities | -41,700,000.00 | -82,400,000.00 |
Increase (decrease) in cash and cash equivalents before effect of exchange rate changes | 2,200,000.00 | -18,600,000.00 |
Effect Of Exchange Rate Changes On Cash And Cash Equivalents | -400,000.00 | 2,400,000.00 |
Cash and cash equivalents | 74,900,000.00 | 58,700,000.00 |
Please note that some sums might not add up.
Position Holder | Short Interest in Percent | Date |
---|---|---|
Millennium Capital Partners LLP | 0.78% | 19.10.23 |
Millennium Capital Partners LLP | 0.58% | 28.07.23 |
Millennium Capital Partners LLP | 0.81% | 01.11.23 |
Millennium Capital Partners LLP | 0.80% | 20.10.23 |
Millennium Capital Partners LLP | 0.70% | 05.10.23 |
Millennium Capital Partners LLP | 0.71% | 13.09.23 |
Millennium Capital Partners LLP | 0.69% | 18.09.23 |
Millennium Capital Partners LLP | 0.60% | 17.08.23 |
Millennium Capital Partners LLP | 0.69% | 07.09.23 |
Total | 6.36% |
GB0009292243
LEI213800UYNPHAUNHPXL67
SectorFTSE 250
Main Stock ExchangeKeep yourself informed with the most recent updates on FinancialReports, IPOs, product advancements, and other significant news.